08.12.2012 Views

20% - Assa Abloy

20% - Assa Abloy

20% - Assa Abloy

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Note 1 cont.<br />

benefits can be reliably measured. Development costs so<br />

reported are amortized over the expected useful life.<br />

Development costs recorded as assets but not yet in use<br />

are subject to annual impairment testing. Costs for development<br />

of existing products are expensed as they are<br />

incurred.<br />

Borrowing costs<br />

Borrowing costs are recognized as expenses in the period<br />

in which they are incurred.<br />

Tax on income<br />

The income statement includes all tax that is to be paid or<br />

received for the current year, adjustments relating to tax<br />

due for previous years, and changes in deferred tax. Tax<br />

sums have been calculated as nominal amounts in accordance<br />

with the tax regulations in each country and in<br />

accordance with tax rates that have either been decided or<br />

have been notified and can confidently be expected to be<br />

confirmed. For items reported in the income statement,<br />

associated tax effects are also reported in the income<br />

statement. The tax effects of items reported directly<br />

against equity are themselves reported against equity.<br />

Deferred tax is accounted for under the liability method.<br />

This means that deferred tax is accounted for on all temporary<br />

differences between the carrying amounts of assets<br />

and liabilities and their respective tax bases. Deferred tax<br />

receivables relating to tax losses carried forward or other<br />

future tax allowances are reported to the extent that it is<br />

probable that the allowance can be set against taxable<br />

income in future taxation. Deferred tax liabilities relating to<br />

temporary differences resulting from investments in subsidiaries<br />

are not reported in the consolidated financial<br />

statements since the Parent company can control the time<br />

at which the temporary differences are cancelled and it is<br />

not considered likely that such cancellation will occur in<br />

the foreseeable future. Deferred tax receivables and<br />

deferred tax liabilities are offset when there is a legal right<br />

to do so and when the deferred tax amounts concern the<br />

same tax authority.<br />

Cash flow statement<br />

The cash flow statement has been prepared according to<br />

the indirect method. The reported cash flow includes only<br />

transactions involving cash payments.<br />

Cash and cash equivalents<br />

‘Cash and cash equivalents’ covers cash and bank balances<br />

and short-term financial investments with durations of less<br />

than three months from the date of acquisition.<br />

Goodwill and acquisition-related intangible assets<br />

Goodwill represents the positive difference between the<br />

cost of acquisition and the fair value of the Group’s share of<br />

the acquired company’s net identifiable assets at the date<br />

of acquisition, and is reported at cost less accumulated<br />

impairment losses. Goodwill is allocated to Cash-Generating<br />

Units (CGU) and each year is systematically tested for<br />

impairment using a valuation model based on discounted<br />

future cash flow. Deferred tax receivables based on local tax<br />

rates are reported in terms of tax-deductible goodwill<br />

(with corresponding reduction of the goodwill value). Such<br />

deferred tax receivables are expensed as the tax deduction<br />

is utilized.<br />

ASSA ABLOY<br />

Annual Report 2007<br />

69<br />

Other acquisition-related intangible assets consist chiefly<br />

of various types of intangible rights such as brands, patents<br />

and customer relationships. Identifiable acquisition-related<br />

intangible assets are initially recognized at fair value at the<br />

date of acquisition and subsequently at cost less accumulated<br />

amortization and impairment losses. Amortization is<br />

on a straight-line basis over estimated useful life. Acquisition-related<br />

intangible assets with indefinite useful life are<br />

tested for impairment every year in the same way as goodwill,<br />

as described above.<br />

Other intangible assets<br />

An intangible asset that is not acquisition-related is<br />

reported only if it is likely that the future economic benefits<br />

associated with the asset will flow to the Group and if the<br />

cost of the asset can be measured reliably. Such an asset is<br />

initially recognized at cost and is amortized over its estimated<br />

useful life, usually between three and five years. Its<br />

carrying amount is cost less accumulated amortization and<br />

impairment losses.<br />

Tangible assets<br />

Tangible assets are reported at cost less accumulated<br />

depreciation and impairment losses. Cost includes expenditure<br />

that can be directly attributed to the acquisition of<br />

the asset. Subsequent expenditure is added to the carrying<br />

amount if it is probable that economic benefits associated<br />

with it will flow to the Group and if the cost can be reliably<br />

measured. Expenditure on repairs and maintenance is<br />

expensed as it is incurred. Depreciable amount is the cost<br />

of an asset less its residual value. No depreciation is applied<br />

to land. For other assets, cost is depreciated over estimated<br />

useful life, which for the Group leads to the following<br />

depreciation periods (on average):<br />

• office buildings, 50 years<br />

• industrial buildings, 25 years<br />

• machinery and other technical plant, 7–10 years<br />

• equipment and tools, 3–6 years.<br />

An asset’s residual value and useful life are reviewed at each<br />

financial year-end and adjusted when needed. Profit or loss<br />

on the disposal of a tangible asset is recognized in the<br />

income statement as ‘Other operating income’ or ‘Other<br />

operating expenses’, based on the difference between the<br />

selling price and the carrying amount.<br />

Leasing<br />

The Group’s leasing is chiefly operational leasing. The leasing<br />

payments are expensed at a constant rate over the period<br />

of the contract and are reported as operating costs.<br />

Impairment<br />

Assets with indefinite useful life are not amortized but are<br />

tested for impairment on an annual basis. For impairment<br />

testing purposes assets are grouped at the lowest organizational<br />

level where there are separate identifiable cash<br />

flows, so called Cash-Generating Units (CGU). For assets<br />

that are depreciated/amortized, impairment testing is carried<br />

out when events or circumstances indicate that the<br />

carrying amount may not be recoverable.<br />

When impairment has been established, the value of<br />

the asset is reduced to its recoverable amount. The recoverable<br />

amount is the higher of the asset’s fair value less<br />

costs to sell, and its value in use.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!